Neeltje Steeghs
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Neeltje Steeghs
Sep 4, 2024, 06:47 |
Insight
Jarushka Naidoo: Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial
Jarushka Naidoo shared on X: "Intracranial activity of Tarlatamab in 2L SCLC in Ph I…
Aug 31, 2024, 20:07 |
Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 9, 2024, 05:53 |
Blog
Nivolumab with and without ipilimumab in solid tumors of high mutational burden - Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared a post on X, about recent paper published in…
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
May 21, 2024, 04:43 |
Blog
Clinical and Translational Oncology PhD Programme participant Alaa Embaby's theses
The Clinical and Translational Oncology PhD Programme shared on LinkedIn: "On Tuesday May 21st, our…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube